Uses of anti-CTLA-4 antibodies

Details for Australian Patent Application No. 2005225227 (hide)

Owner Pfizer Products Inc.

Inventors Mueller, Eileen Elliott; Gomez-Navarro, Jesus; Noe, Dennis Alan; Hanson, Douglas Charles

Agent Shelston IP

Pub. Number AU-A-2005225227

PCT Pub. Number WO2005/092380

Priority 60/556,801 26.03.04 US

Filing date 14 March 2005

Wipo publication date 6 October 2005

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/092380 Priority application(s): WO2005/092380

7 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005225236-Tape printer

2005225223-Single needle device for extracorporeal treatment of blood.